Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 3/20 | 0.69 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.69 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL77074 | 0.83 | MAPK1 (0.69) | ROCK2ROCK1HPGDGAAMEN1 | |
| SCHEMBL2562667 | 0.81 | ROCK1 (1.00) | ROCK2ROCK1 | |
| SCHEMBL91397 | 0.81 | ROCK2 (0.62) | ROCK2ROCK1MEN1KMT2A | |
| SCHEMBL91529 | 0.78 | ROCK1 (0.70) | ROCK2ROCK1GAAMEN1KMT2A | |
| SCHEMBL2380162 | 0.74 | RXFP1 (0.55) | ROCK2ROCK1GAAMEN1KMT2A | |
| SCHEMBL10084544 | 0.74 | LMNA (0.71) | ROCK1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL91393 | 0.74 | ROCK2 (0.64) | ROCK2ROCK1MEN1KMT2AMAPT | |
| SCHEMBL2378961 | 0.74 | GAA (0.46) | ROCK2ROCK1GAAMEN1KMT2A | |
| SCHEMBL91525 | 0.73 | LMNA (0.70) | ROCK2ROCK1GAAMEN1KMT2A | |
| SCHEMBL91611 | 0.73 | FPR2 (0.55) | ROCK2ROCK1KMT2AMAPTRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129415-B2 | Fungicide hydroximoyl-tetrazole derivatives | BAYER CROPSCIENCE AG (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20090192196-A1 | Fungicide hydroximoyl-tetrazole derivatives | BAYER CROPSCIENCE AG (DE) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192196-A1 | Fungicide hydroximoyl-tetrazole derivatives | HAAO, HAO1, CYP51A1 | ROCK2 2794/4885ROCK1 2709/4885HPGD 1636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.